FDA strikes cautious tone ahead of Pfizer booster meeting
Data published Wednesday from the agency adds to the debate over whether an extra dose of the vaccine is warranted.
Data published Wednesday from the agency adds to the debate over whether an extra dose of the vaccine is warranted.